Xynomic Pharmaceuticals
PrivateLast Round
M&A
May 15, 2019
Est. Valuation
$350M
Total Funding Raised
$26.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Xynomic Pharmaceuticals is a biopharmaceutical company that focuses on in-licensing, developing, and commercializing oncology drug candidates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xynomic Pharmaceuticals Comparables
Compare Xynomic Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 成都赜灵生物医药科技有限公司 | 83% | |
| EOC Pharma | 80% | |
| HUYA Bioscience International | 80% | |
Xynomic Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 15, 2019 | ||||
| Series B | Aug 1, 2018 | ||||
| Debt | May 1, 2018 | ||||
| Debt | Apr 1, 2018 | ||||
| Debt | Aug 15, 2017 |
Xynomic Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northern Light Venture Capital | Series B |
| Jingxu Venture Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 49% MoM, reaching 1.4K.
- May 3, 2025
Monthly visitors grew 156% MoM, reaching 1.4K.
Xynomic Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xynomic Pharmaceuticals's valuation, stock price, and market status.